Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
06/2003
06/19/2003US20030113306 Probiotic lactobacillus casei strains
06/19/2003US20030113297 Contains active ingredients from the fruiting body and the mycelium of Antrodia Cinnamomea, which is a kind of mushroom that grows inside an unique plant in Taiwan, a Cinnamomum kanehirae tree, cures alcohol related liver cancer
06/19/2003US20030113276 Flexible polybutene strips for preventing gingivitis/whitening of teeth
06/19/2003CA2469893A1 Phenylalkynes
06/19/2003CA2469889A1 Salt forms of e-2-methoxy-n-(3-(4-(3-methyl-pyridin-3-yloxy)-phenylamino)-quinazolin-6-yl)-allyl)-acetamide, its preparation and its use against cancer
06/19/2003CA2469858A1 Functionalized higher diamondoids
06/19/2003CA2469607A1 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity
06/19/2003CA2468892A1 Vitamin d analogues
06/19/2003CA2468659A1 Urea substituted imidazopyridines
06/19/2003CA2468544A1 Vanilloid receptor ligands
06/19/2003CA2468174A1 Amide substituted imidazopyridines
06/19/2003CA2468164A1 Sulfonamido substituted imidazopyridines
06/19/2003CA2468156A1 Azolopyrimidinone compounds and their use
06/19/2003CA2467689A1 Stabilization of hypoxia inducible factor (hif) alpha using inhibitors of hif prolyl hydroxylase
06/19/2003CA2467573A1 3-cyanoquinolines as inhibitors of egf-r and her2 kinases
06/19/2003CA2465759A1 Method for administering birb 796 bs
06/18/2003EP1319709A1 Disruption of the glutathione S-transferase-omega-1 gene
06/18/2003EP1319410A1 Use of micro-organisms for a directed delivery of substances to specific parts of the gut
06/18/2003EP1319402A1 Ige production inhibitors
06/18/2003EP1319345A1 The effect of a buffering agent on acidogenesis of plaque
06/18/2003EP1319007A1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
06/18/2003EP1319003A1 Xanthine phosphodiesterase v inhibitors
06/18/2003EP1318997A1 Pyrazole compounds useful as protein kinase inhibitors
06/18/2003EP1318996A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318994A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318993A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318991A1 Benzoic acid derivatives and uses thereof
06/18/2003EP1318988A2 Ligands for monoamine receptors and transporters, and methods of use thereof (neurotransmission)
06/18/2003EP1318983A2 Substituted imidazoles as dual histamine h1 and h3 agonists or antagonists
06/18/2003EP1318981A2 Quinoline and quinazoline derivatives as ligands for the neuropeptide y receptor
06/18/2003EP1318979A1 Cyclopentane derivatives as therapeutic agents
06/18/2003EP1318977A1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
06/18/2003EP1318836A2 Treatment of hyperproliferative diseases
06/18/2003EP1318816A1 Corticosteroid formulation comprising less than 2.5 mg prednisolone for once daily administration
06/18/2003EP1318814A2 Triazole compounds useful as protein kinase inhibitors
06/18/2003EP1318809A1 Micronized torsemide
06/18/2003EP1318804A1 Iron compositions
06/18/2003EP1318761A1 Concurrent tooth repositioning and substance delivery
06/18/2003EP1075475B1 Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
06/18/2003EP1015451B1 Tetrahydro gamma-carbolines
06/18/2003EP1011709A4 Inhibition of apoptotis using prosaposin receptor agonists
06/18/2003EP0819125B1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin
06/18/2003CN1425016A Benzoxathiepino [3,4-b] pyridine derivatives, process for their preparation and their use as medicaments
06/18/2003CN1425010A Cyclic compound
06/18/2003CN1424999A Aminoalcohol derivatives
06/18/2003CN1424915A Oral, nasal and pulmonary dosage formulations of copolymer1
06/18/2003CN1424912A Composition comprising camptothecin and pyrimidine derivative for the treatment of cancer
06/18/2003CN1424910A IL-8 receptor antagonists
06/18/2003CN1424392A Nutritive wine for male
06/18/2003CN1424318A Structure of phenethyl alcohol glycoside compound and its use
06/18/2003CN1424110A Vaccine adjuvant against hepatitis B
06/18/2003CN1424099A Medicines for treating hepatitis B and preparation thereof
06/18/2003CN1424090A Chinese medicine preparation for treating toothache and producing method thereof
06/18/2003CN1424085A Process for preparing Tibet medicine
06/18/2003CN1424076A Healthy food for loosing bowel to relieve constipation
06/18/2003CN1424074A Capsule for constipation and its preparing method
06/18/2003CN1424072A Healthy fermentative wine preparation
06/18/2003CN1424071A Auxiliary medicine for treating esophagus cancer and processing method thereof
06/18/2003CN1424064A Healthy medicinal spirit for tonifying kidney and strengthening Yang
06/18/2003CN1424062A Chinese medicine for gastrointestinal cancers and its preparation
06/18/2003CN1424059A Chinese medicine for treating liver illness
06/18/2003CN1424052A Medicine for treating chronic hepatitis B
06/18/2003CN1424050A Capsules of rana amurensis ovary
06/18/2003CN1424048A Medicine for treating bacillary dysentery and enteritis
06/18/2003CN1424047A Safety quick effective rectal suppository made of glycerin, sodium chloride and water
06/18/2003CN1424046A Use of Chinese angelica polysaccharide in oral colon orientation releasing pro-drug
06/18/2003CN1424032A Capsule agent with grape-seed extracts as raw material
06/18/2003CN1111541C Polymannuronic acid sulfate
06/18/2003CN1111529C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111528C Piperazino derivatives as neurokinin antagonists
06/18/2003CN1111520C Matrix metalloprotease inhibitors
06/18/2003CN1111418C Medicine for treating constipation and its preparing process
06/18/2003CN1111417C Medicine for enteritis and acute and chronic diarrhea and its preparing process
06/18/2003CN1111414C Use of magnesium salts or magnesium complex as production of medicines
06/18/2003CN1111357C Food products having enhanced cocoa polyphenol content and processes for producing same
06/17/2003US6579982 Treating inflammation, cancer
06/17/2003US6579900 Can be used to reduce pain, reducing nausea in an individual undergoing chemotherapy, suppressing appetite, reducing intraocular pressure, and suppressing the immune system in an individual with an organ transplant.
06/17/2003US6579896 Method for treating allergies using substituted pyrazoles
06/17/2003US6579890 Matrix metalloprotease inhibitors
06/17/2003US6579884 Gastrointestinal inflammatory diseases, antisecretory; infection by Helicobacter pylori of human gastric mucosa; Substituted imidazo(1,2-a)pyridines
06/17/2003US6579883 Fluorinated 3,4-dihydroquinoline derivatives used as NOS inhibitors
06/17/2003US6579874 Substituted azoles
06/17/2003US6579872 Bezamide derivatives for the treatment of diseases mediated by cytokines
06/17/2003US6579870 5-(1,4-diazepan-1-yl)-2-((3 -fluorophenyl)sulfonyl)phenylamine for example; treatment of diseases or disorders of the central nervous system; modulation of serotonin (5-HT) activity
06/17/2003US6579861 Administering alpha -hydroxy-2-methylene-19-nor-homopregnacalciferol for therapy of psoriasis
06/17/2003US6579851 Effects of glucagon-like peptide-1 (7-36) on antro-pyloro-duodenal motility
06/17/2003CA2307553C Citrus peel extract as inhibitor of acyl coa-cholesterol-o-acyltransferase, inhibitor of macrophage-lipid complex accumulation on the arterial wall and preventive or treating agent for hepatic diseases
06/17/2003CA2226422C Use of indigestible oligosaccharides to prevent and treat diarrhea
06/17/2003CA2183472C Liquid paraffin oil and lactulose-based hypocaloric laxative jelly and method for its preparation
06/17/2003CA2129820C Dna sequences encoding novel growth/differentiation factors
06/14/2003CA2364985A1 Imidazo(2,1-b)thiadiazole sulfonamides
06/12/2003WO2003048199A1 Cytotoxic protein and utilization thereof
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048162A1 Novel crystalline compound
06/12/2003WO2003048160A1 Ring fused pyrazole derivatives
06/12/2003WO2003048153A1 Process for the preparation of compositions having an increased amount of pharmaceutically active salts of rotamers
06/12/2003WO2003048141A1 Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof
06/12/2003WO2003048129A1 Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the use thereof as medicaments, in addition to a medicament containing same
06/12/2003WO2003048125A1 Aminotetralin derivatives as muscarinic receptor antagonists
06/12/2003WO2003048124A1 4-piperidinyl alkylamine derivatives as muscarinic receptor antagonists
1 ... 873 874 875 876 877 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 ... 1258